StockVS

NASDAQ · Medical Devices · USD

Semler Scientific, Inc. (SMLR) Stock Analysis

Semler Scientific, Inc. (SMLR) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

SMLR

$20.33

$0.00 (0.00%)

Last trade January 21, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SMLR with… →

SMLR Key Statistics

As of Jan 21, 2026
Trading
Open
$20.33
Previous Close
$20.33
52-Week Range
14.89–54.40
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.32
Valuation
Market Cap
$311.11M
P/E Ratio
3.93
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
254.43
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
8.42
EPS (ttm)Profit attributable to each share over the last twelve months.
5.18
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
130.80%
1-Year Return
−68.69%
Dividend and dates
Avg Volume
643.89K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SMLR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+32.96%
2025−71.69%
2024 (partial year)−11.97%

As of January 21, 2026.

SMLR Valuation vs Medical Devices Median

Median of 151 stocks
MetricSMLRMedical Devices medianvs median
P/E3.9326.800.1x the median
P/S ratio8.422.98183% above
Profit margin130.80%−1.69%132.5 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Semler Scientific, Inc. (SMLR) is capitalised at $311.11M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 79.

Over the past 52 weeks the price has ranged from $14.89 to $54.40. SMLR last closed at $20.33 on January 21, 2026. The close was unchanged from the previous session. The latest close sits 36.58% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is $36.96M. The reported profit margin is 130.8%. That is 132.5 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 5.18.

Valuation Assessment

SMLR trades at a trailing price-to-earnings ratio of 3.93. That is 0.1 times the Medical Devices median of 26.8. The forward P/E on file is 254.43. The price-to-sales ratio is 8.42. On price-to-sales that is 182.87% above the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.32. Daily returns over the trailing 1 year annualize to a volatility of 97.62%. Over the trailing twelve months the price has returned −68.69%.

Growth & Income

No dividend is on file for SMLR.

So far in 2026 the price is +32.96%. The record holds one complete calendar year, 2025, which returned −71.69%.

Peer Comparison

Semler Scientific, Inc. (SMLR) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Semler Scientific, Inc. SMLR $311.11M 3.9
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Semler Scientific, Inc. trades at a P/E of 3.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of January 21, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Semler Scientific, Inc.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Visit website →